UA cancer researcher receives European award
Summary:
Laurence Hurley, a professor at University of Arizona and a member of the Arizona Cancer Center, will be honored next month by the Royal Society of Chemistry for landmark achievements in the treatment of cancer. The Royal Society of Chemistry is the largest organization in Europe for advancing the chemical sciences.
Full Story:
Laurence Hurley, a professor at University of Arizona and a member of the Arizona Cancer Center, will be honored next month by the Royal Society of Chemistry for landmark achievements in the treatment of cancer. Hurley will accept the award on Oct. 25 in London and spend the second half of October lecturing throughout the United Kingdom.
The George and Christine Sosnovsky Cancer Research Award recognizes outstanding accomplishments in the prevention, control, and cure of cancers using chemotherapy, gene therapy, and immunotherapy.
Hurley, who joined the UA faculty in 2000, directs research projects that focus on the design and development of new ways to destroy cancer cells. He is also a founder of Cylene Pharmaceuticals and chairman of its scientific advisory board.
In July 2005 Cylene announced that it had initiated clinical trials for a class of drugs derived from a molecule first identified by Hurley and his colleagues at the University of Texas in the late 1990s. The molecule, CX-3543, selectively induces cancer cell death.
The Royal Society of Chemistry is the largest organization in Europe for advancing the chemical sciences.
For more information:
Cancer Researcher to win European award, UA Press Release, 9/8/2005